Background
Objective
Study Design
Results
Conclusion
Key words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Obstetrics & GynecologyReferences
- Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study.Fertil Steril. 2003; 79: 577-584
- Trends in the incidence, rate and treatment of miscarriage-nationwide register-study in Finland, 1998-2016.Hum Reprod. 2019; 34: 2120-2128
- Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome.Hum Reprod Update. 2014; 20: 262-278
- Asherman syndrome - one century later.Fertil Steril. 2008; 89: 759-779
- Traumatic intra-uterine adhesions.J Obstet Gynaecol Br Emp. 1950; 57: 892-896
- Intrauterine adhesions: an updated appraisal.Fertil Steril. 1982; 37: 593-610
- Hysteroscopic findings after missed abortion.Fertil Steril. 1992; 58: 508-510
- Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy - a prospective study.Hum Reprod. 1993; 8: 442-444
- [Early diagnosis of congenital and acquired intrauterine causes of abortion by post-abortion hysteroscopy].Geburtshilfe Frauenheilkd. 1996; 56: 542-545
- Prevalence of uterine synechia after abortion evacuation curettage.Sao Paulo Med J. 2007; 125: 261-264
- “See and treat” hysteroscopy after missed abortion.Minim Invasive Ther Allied Technol. 2011; 20: 14-17
- Post-abortion hysteroscopy: a method for early diagnosis of congenital and acquired intrauterine causes of abortions.Eur J Obstet Gynecol Reprod Biol. 2011; 156: 101-104
- Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial.Fertil Steril. 2017; 107: 1223-1231.e3
- New crosslinked hyaluronan gel for the prevention of intrauterine adhesions after dilation and curettage in patients with delayed miscarriage: a prospective, multicenter, randomized, controlled trial.J Minim Invasive Gynecol. 2019; 26: 94-99
- Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study.Hum Reprod. 2003; 18: 1918-1921
- Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study.Hum Reprod. 2004; 19: 1461-1464
- Meta-analysis on the use of hyaluronic acid gel to prevent intrauterine adhesion after intrauterine operations.Exp Ther Med. 2020; 19: 2672-2678
- The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Mullerian anomalies and intrauterine adhesions.Fertil Steril. 1988; 49: 944-955
- Reproductive performance after the application of hyaluronic acid gel after dilation and curettage in women who have experienced at least one previous curettage: long-term results of a multicenter prospective randomized trial.Fertil Steril. 2018; 110: 1231-1238
- Pregnancy and neonatal outcomes 42 months after application of hyaluronic acid gel following dilation and curettage for miscarriage in women who have experienced at least one previous curettage: follow-up of a randomized controlled trial.Fertil Steril. 2020; 114: 601-609
Article Info
Publication History
Publication stage
In Press Journal Pre-ProofFootnotes
J.S. has been invited by Nordic Pharma to present the first results of the HYFACO study at the congress of the American Association of Gynecologic Laparoscopists, Vancouver, Canada in 2019. The remaining authors report no conflict of interest.
This research was sponsored by Assistance Publique - Hôpitaux de Paris (Délégation à la Recherche Clinique et à l’Innovation). The study was funded by a grant from Programme Hospitalier de Recherche Clinique - PHRC 2013-032 (Ministry of Health). Hyalobarrier was provided by Nordic Pharma. Neither the funding source nor Nordic Pharma were ever involved in the study design, data collection, data analysis, or data interpretation.
Clinical trial information: The study was registered on ClinicalTrials.gov.
1. Date of registration: September 22, 2014.
2. Date of initial participant enrollment: November 14, 2014.
3. Clinical trial identification number: NCT02248376.
4. URL of the registration site: https://clinicaltrials.gov/ct2/show/NCT02248376.
5. Data sharing information:
a. Will individual participant data be available (including data dictionaries)?
The datasets generated during and/or analyzed during the current study are available from the sponsor via the corresponding author on reasonable request.
b. What data in particular will be shared?
All data may be available on reasonable request.
c. What other documents will be available (eg, study protocol, statistical analysis plan, etc.)?
Both the study protocol and the statistical analysis plan are available on request.
d. When will data be available (start and end dates)?
The data are available on reasonable request from the date of submission.
e. How will data be shared (including with whom, for what types of analyses, and by what mechanism)?
Data will be shared through the corresponding author and the sponsor.
Cite this article as: Sroussi J, Bourret A, Pourcelot AG, et al. Does hyaluronic acid gel reduce intrauterine adhesions after dilation and curettage in women with miscarriage? A Multicentric randomized controlled trial (HYFACO Study). Am J Obstet Gynecol 2022;XX:x.ex–x.ex.
